(UroToday.com) As a portion of the European Society for Medical Oncology (ESMO) Annual Congress, an Educational Session focused on the management of patients with node-positive locally advanced prostate cancer was held. In this context, Dr. Chris Parker discussed the role of radiotherapy for these patients. He began by emphasizing that there are no randomized controlled trials testing the role of radiotherapy in this disease setting.